Abbott received FDA Emergency Use Authorization and launched test to detect novel Coronavirus
On Mar. 18, 2020, Abbott announced that the FDA had issued Emergency Use Authorization (EUA) for the company’s molecular test for novel coronavirus (COVID-19). Abbott immediately began shipping 150,000 Abbott RealTime SARS-CoV-2 EUA tests to existing customers in the U.S. The tests are used on the company’s m2000οΎ RealTime System. Abbott will be working with health systems and government authorities to deploy additional m2000 systems where they are needed.
Tags:
Source: Abbott
Credit:
